Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Adeshwar MeditexBOM:543309 70 3-Year ROIIC % is 60.31 as of Mar. 2026. GuruFocus rates BOM:543309 with a GF Score™ of 70/100 and a GF Value™ of ₹14.96 (Modestly Overvalued). The stock has 7 warning signs investors should review. Among 794 Medical Devices & Instruments companies, Adeshwar Meditex ranks better than 84.38% on this metric.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Adeshwar Meditex's 3-Year ROIIC % for the quarter that ended in Mar. 2026 was 60.31%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Adeshwar Meditex's 3-Year ROIIC % or its related term are showing as below:
BOM:543309's 3-Year ROIIC % is ranked better than 84.38% of 794
companies
in the Medical Devices & Instruments industry
Industry Median: 1.62
vs BOM:543309: 60.31
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Adeshwar Meditex 3-Year ROIIC % Related Terms
Adeshwar Meditex 3-Year ROIIC % Historical Data
* Premium members only.
The historical data trend for Adeshwar Meditex's 3-Year ROIIC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:543309 vs ISRG, BDX, RMD: 3-Year ROIIC % Comparison
For the Medical Instruments & Supplies subindustry, Adeshwar Meditex's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Adeshwar Meditex 3-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Adeshwar Meditex's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Adeshwar Meditex's 3-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Adeshwar Meditex (BOM:543309) has a 3-Year ROIIC % of 60.31 as of Mar. 2026. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Adeshwar Meditex and its competitors. According to the industry distribution chart, Adeshwar Meditex ranks #124 out of 794 companies in the Medical Devices & Instruments industry, placing it in the top 15.6%.
Is Adeshwar Meditex's 3-Year ROIIC % too high?
Adeshwar Meditex's current 3-Year ROIIC % is 60.31. The Medical Devices & Instruments industry median 3-Year ROIIC % is 1.62. Adeshwar Meditex's value of 60.31 is 3622.8% above this industry median. Based on the distribution chart, Adeshwar Meditex ranks #124 out of 794 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Adeshwar Meditex has a GF Score™ of 70/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Adeshwar Meditex's 3-Year ROIIC % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Adeshwar Meditex ranks #124 out of 794 companies for 3-Year ROIIC %. This places Adeshwar Meditex in the top 16% of its industry — outperforming the majority of peers. The industry median 3-Year ROIIC % is 1.62. Adeshwar Meditex's value of 60.31 is 3622.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Devices & Instruments company?
The median 3-Year ROIIC % among Medical Devices & Instruments companies is 1.62, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Adeshwar Meditex's current 3-Year ROIIC % of 60.31 is 3622.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Adeshwar Meditex and its competitors. For the Medical Devices & Instruments industry, the median 3-Year ROIIC % is 1.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Adeshwar Meditex's current 3-Year ROIIC % is 60.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adeshwar Meditex stock overvalued right now?
Based on GuruFocus' analysis, Adeshwar Meditex (BOM:543309) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹14.96, compared to a current price of ₹16.95 — trading 13.3% above its estimated fair value. The current 3-Year ROIIC % is 60.31 and 3622.8% above the Medical Devices & Instruments industry median of 1.62. Adeshwar Meditex's overall GF Score™ is 70/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Adeshwar Meditex (BOM:543309), the current 3-Year ROIIC % is 60.31 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Adeshwar Meditex (BOM:543309) Overvalued in 2026?
Based on GuruFocus' analysis, Adeshwar Meditex stock appears to be overvalued.
The current stock price of ₹16.95 is trading 13.3% above its estimated GF Value™ of ₹14.96.
GuruFocus considers Adeshwar Meditex to be Modestly Overvalued.
Key valuation signals for BOM:543309:
3-Year ROIIC %: 60.31
GF Value™: ₹14.96 vs. price of ₹16.95 (13.3% above fair value)
Industry Position: 3622.8% above the Medical Devices & Instruments median (#124 of 794)
No single metric tells the full story. See the BOM:543309 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Adeshwar Meditex Ltd is engaged in manufacturing surgical dressings and external preparations products such as Sterile surgical wound dressing, Combine dressing, Gauze Dressing and Cotton Products, Medical Bandages and Plaster, Antiseptics / Disinfectants, and others.
70GF Score
Get the complete analysis for BOM:543309
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543309 has been successfully added to your 
